Compound 543
Identifiers
- Canonical SMILES:
COCCCNC(=O)c1ccc(cc1)-n1[nH]c2c3cnn(C)c3nc(-c3cccc(c3)C(F)(F)F)c2c1=O
- InChi:
InChI=1S/C26H23F3N6O3/c1-34-23-19(14-31-34)22-20(21(32-23)16-5-3-6-17(13-16)26(27,28)29)25(37)35(33-22)18-9-7-15(8-10-18)24(36)30-11-4-12-38-2/h3,5-10,13-14,33H,4,11-12H2,1-2H3,(H,30,36)
- InChiKey:
CMZPWMJLWIGGLL-UHFFFAOYSA-N
External links
168318176 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD80 / CD28 | 6.96 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 524.18 g/mol | |||
HBA | 9 | |||
HBD | 2 | |||
HBA + HBD | 11 | |||
AlogP | 4.08 | |||
TPSA | 101.38 | |||
RB | 8 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4919 | N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide | DB08349 | |
0.4798 | Riociguat | DB08931 | |
0.4794 | MK-0249 | DB11910 | |
0.4737 | 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE | DB07218 | |
0.4723 | ATX-914 | DB12673 | |
0.4708 | Tepotinib | DB15133 | |
0.4698 | Ispinesib | DB06188 | |
0.4648 | Vericiguat | DB15456 | |
0.4604 | Risdiplam | DB15305 | |
0.4559 | Merestinib | DB12381 | |
0.4553 | Decoglurant | DB11923 | |
0.4511 | MK-0893 | DB12044 | |
0.4486 | Dilmapimod | DB12140 | |
0.4483 | 1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide | DB06909 | |
0.4410 | 5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine | DB08534 |